
    
      This ease of use study involves the use of FDA 510(k) cleared hemodialyzers and will have no
      impact on the patient's routine dialysis therapy. This study is aimed at obtaining feedback
      from the nursing and technical staff regarding the use and thrombogenicity of the Polyflux
      HD-C4 Big, and Fresenius Optiflux 180NR or 200NR dialyzers. The dialysis nursing staff will
      complete ease of use and thrombogenicity assessments following routine dialysis therapy. Any
      adverse events will be tracked for the study patients.
    
  